Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorZhujiang Hospital
About this trial
To provide a comprehensive MALDI-TOF mass spectrometry method for detecting, characterizing, and quantifying M-protein, and to track M-protein in a very sensitive and specific manner during patient treatment, providing a more precise test for diagnosing disease and monitoring patient response to treatment.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Observational studies, no intervention
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Zhujiang Hospital
Lead sponsor
National Natural Science Foundation of China
Collaborator
Source ClinicalTrials.gov